157 related articles for article (PubMed ID: 29984527)
41. Discovery of novel CK2 leads by cross-docking based virtual screening.
Sun H; Wu X; Xu X; Jiang Z; Liu Z; You Q
Med Chem; 2014; 10(6):628-39. PubMed ID: 24286395
[TBL] [Abstract][Full Text] [Related]
42. Identification of Novel PI3Kδ Selective Inhibitors by SVM-Based Multistage Virtual Screening and Molecular Dynamics Simulations.
Liang JW; Wang S; Wang MY; Li SL; Li WQ; Meng FH
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795217
[TBL] [Abstract][Full Text] [Related]
43. Discovery of novel wee1 inhibitors via structure-based virtual screening and biological evaluation.
Li Y; Pu Y; Liu H; Zhang L; Liu X; Li Y; Zuo Z
J Comput Aided Mol Des; 2018 Sep; 32(9):901-915. PubMed ID: 30182144
[TBL] [Abstract][Full Text] [Related]
44. The potent Cdc7-Dbf4 (DDK) kinase inhibitor XL413 has limited activity in many cancer cell lines and discovery of potential new DDK inhibitor scaffolds.
Sasi NK; Tiwari K; Soon FF; Bonte D; Wang T; Melcher K; Xu HE; Weinreich M
PLoS One; 2014; 9(11):e113300. PubMed ID: 25412417
[TBL] [Abstract][Full Text] [Related]
45. In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study.
Kumar H; Raj U; Gupta S; Varadwaj PK
J Biomol Struct Dyn; 2016 Oct; 34(10):2171-83. PubMed ID: 26479578
[TBL] [Abstract][Full Text] [Related]
46. A generic time-resolved fluorescence assay for serine/threonine kinase activity: application to Cdc7/Dbf4.
Xu K; Stern AS; Levin W; Chua A; Vassilev LT
J Biochem Mol Biol; 2003 Jul; 36(4):421-5. PubMed ID: 12895303
[TBL] [Abstract][Full Text] [Related]
47. Discovery of XL413, a potent and selective CDC7 inhibitor.
Koltun ES; Tsuhako AL; Brown DS; Aay N; Arcalas A; Chan V; Du H; Engst S; Ferguson K; Franzini M; Galan A; Holst CR; Huang P; Kane B; Kim MH; Li J; Markby D; Mohan M; Noson K; Plonowski A; Richards SJ; Robertson S; Shaw K; Stott G; Stout TJ; Young J; Yu P; Zaharia CA; Zhang W; Zhou P; Nuss JM; Xu W; Kearney PC
Bioorg Med Chem Lett; 2012 Jun; 22(11):3727-31. PubMed ID: 22560567
[TBL] [Abstract][Full Text] [Related]
48. Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression.
Sheu YJ; Stillman B
Mol Cell; 2006 Oct; 24(1):101-13. PubMed ID: 17018296
[TBL] [Abstract][Full Text] [Related]
49. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
50. Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation.
Bonte D; Lindvall C; Liu H; Dykema K; Furge K; Weinreich M
Neoplasia; 2008 Sep; 10(9):920-31. PubMed ID: 18714392
[TBL] [Abstract][Full Text] [Related]
51. Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.
Jung ME; Byun BJ; Kim HM; Lee JY; Park JH; Lee N; Son YH; Choi SU; Yang KM; Kim SJ; Lee K; Kim YC; Choi G
Bioorg Med Chem Lett; 2016 Jun; 26(11):2719-23. PubMed ID: 27106709
[TBL] [Abstract][Full Text] [Related]
52. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
[TBL] [Abstract][Full Text] [Related]
53. Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
Zhu LX; Liu Q; Hua YF; Yang N; Zhang XG; Ding X
Comput Biol Chem; 2019 Jun; 80():324-332. PubMed ID: 31078911
[TBL] [Abstract][Full Text] [Related]
54. Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design.
Han W; Ding Y; Xu Y; Pfister K; Zhu S; Warne B; Doyle M; Aikawa M; Amiri P; Appleton B; Stuart DD; Fanidi A; Shafer CM
J Med Chem; 2016 Apr; 59(7):3034-45. PubMed ID: 27002243
[TBL] [Abstract][Full Text] [Related]
55. Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening.
Geldenhuys WJ; Talasila PK; Sadana P
Bioorg Med Chem Lett; 2012 Sep; 22(17):5675-8. PubMed ID: 22858098
[TBL] [Abstract][Full Text] [Related]
56. A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response.
FitzGerald J; Murillo LS; O'Brien G; O'Connell E; O'Connor A; Wu K; Wang GN; Rainey MD; Natoni A; Healy S; O'Dwyer M; Santocanale C
PLoS One; 2014; 9(6):e98891. PubMed ID: 24902048
[TBL] [Abstract][Full Text] [Related]
57. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
[TBL] [Abstract][Full Text] [Related]
58. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.
John A; Sivashanmugam M; Umashankar V; Natarajan SK
J Biomol Struct Dyn; 2017 Aug; 35(10):2155-2168. PubMed ID: 27373313
[TBL] [Abstract][Full Text] [Related]
59. Machine Learning Classification Models to Improve the Docking-based Screening: A Case of PI3K-Tankyrase Inhibitors.
Berishvili VP; Voronkov AE; Radchenko EV; Palyulin VA
Mol Inform; 2018 Nov; 37(11):e1800030. PubMed ID: 29901257
[TBL] [Abstract][Full Text] [Related]
60. Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships.
Vanotti E; Amici R; Bargiotti A; Berthelsen J; Bosotti R; Ciavolella A; Cirla A; Cristiani C; D'Alessio R; Forte B; Isacchi A; Martina K; Menichincheri M; Molinari A; Montagnoli A; Orsini P; Pillan A; Roletto F; Scolaro A; Tibolla M; Valsasina B; Varasi M; Volpi D; Santocanale C
J Med Chem; 2008 Feb; 51(3):487-501. PubMed ID: 18201066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
